- Hopes are rising for a working vaccine as the world continues to battle with the deadly COVID-19
- Two projects in the UK and the US have reported promising results in their early experiments
- Experimental jabs are being developed by these teams and they both say the results are promising
PAY ATTENTION: Click “See First” under the “Following” tab to see Legit.ng News on your Facebook News Feed!
As the world battles with the deadly COVID-19, hopes are rising for a working vaccine in the United Kingdom and the United States.
Two projects in the UK and the US have reported promising results in their early experiments, Daily Trust reports.
Teams from Oxford University and the American pharmac*utical company Moderna have been developing experiment jabs for months.
Legit.ng gathers that the teams are trying to protect millions of people from being infected with COVID-19 in the future.
Both teams have revealed that people in their studies are showing signs of immunity.
Oxford scientists said they are 80 per cent confident that they can have a jab available by September.
Researchers said antibodies and white blood cells called T cells are being developed by people that are given the Oxford vaccine.
The antibodies and white blood cells will help their bodies fight off the virus if they get infected.
According to experts at Moderna, based in Cambridge, Massachusetts, participants in their trial all successfully developed antibodies.
In other news, Nigerian universities’ scientists under the aegis of COVID-19 Research Group say they have discovered COVID-19 vaccine.
The scientists made the disclosure on Friday, June 19, saying the vaccine was being developed locally in Africa for Africans but would also work for other continents when unveiled,
The leader of the team, Dr Oladipo Kolawole, said it would take a minimum of 18 months for the vaccine to be unveiled to the public.
He said this is because a lot of analysis and studies, as well as approvals by medical authorities, were still required.
Kolawole said the study, which led to the medical breakthrough, had enjoyed initial funding by the Trinity Immunodeficient Laboratory and Helix Biogen Consult, Ogbomosho, to the tune of about N7.8 million.
Coronavirus: People from other countries are happy, Nigerians are not | Legit TV